Browse by all authors Browse By Author Name - Elliott,+S.+L.

Browse Results (8 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., Clarke, B., Slaughter, R., Falk, M. C., Douglass, J., Williams, T., Elliott, S. L. and Moss, D. J. (1999) Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America, 96 18: 10391-10396. doi:10.1073/pnas.96.18.10391 91   202 Cited 225 times in Scopus225 0
Mateo, L. A., Gardner, J., Chen, Q. Y., Schmidt, C., Down, M., Elliott, S. L., Pye, S. J., Firat, H., Lemmonier, F. A., Cebon, J. and Suhrbier, A. (1999) An HLA-A2 polyepitope vaccine for malenoma immunotherapy. Journal of Immunology, 163 7: 4058-4063. 64   64
Davis, J. E., Sherritt, M. A., Bharadwaj, M., Morrison, L. E., Elliott, S. L., Kear, L. M., Maddicks-Law, J., Kotsimbos, T., Gill, D., Malouf, M., Falk, M. C., Khanna, R. and Moss, D. J. (2004) Determining virological, serological and immunological parameters of EBV infection in the development of PTLD. International Immunology, 16 7: 983-989. doi:10.1093/intimm/dxh099 99   18 Cited 19 times in Scopus19 0
Moss, D., Khanna, R., Sherritt, M., Elliott, S. L. and Burrows, S. R. (1999) Developing immunotherapeutic strategies for the control of Epstein-Barr virus-associated malignancies.. Journal of acquired immune deficiency syndromes and human retrovirology, 21 S80-S83. 41  
Woodberry, T., Gardner, J., Mateo, Luis A., Eisen, D., Medveczky, J., Ramshaw, I. A., Thomson, S. A., Ffrench, R. A., Elliott, S. L., Firat, Hüseyin, Lemonnier, F. A. and Suhrbier, Andreas (1999) Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8+ cytotoxic T-Cell epitopes. Journal of Virology, 73 7: 5320-5325. 31   48 Cited 60 times in Scopus60
Bharadwaj, M., Rosenstengel, A., Elliott, S. L., Le, T., Lawrence, G., Allworth, A. M., Moss, D. J. and Suhrbier, A. (1999). Phase I human clinical trial of an Epstein-Barr virus vaccine. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Centre., QIMR, Brisbane, (83). 21st - 27th October, 1999. 34  
Woodberry, T., Gardner, J., Mateo, L., Eisen, D., Medveczky, J., Ramshaw, I. A., Thomson, S. A., French, R. A., Elliott, S. L. and Suhrbier, A. (1999). Polytope vaccine strategy for the co-delivery of multiple HIV CD8+ cytotoxic T cell epitopes. In: Royal Brisbane Hospital Health Care Symposium. Royal Brisbane Hospital Health Care Symposium, Westpac Auditorium Bancroft Cen., QIMR, Brisbane, (82-82). 21 - 27 Oct, 1999. 34  
Sherritt, M. A., Bharadwaj, M., Burrows, J. M., Morrison, L. E., Elliott, S. L., Davis, J. E., Kear, L. M., Slaughter, R. E., Bell, S. C., Galbraith, A. J., Khanna, R. and Moss, D. J. (2003) Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from post-transplant lymphoma after adoptive immunotherapy. Transplantation, 75 9: 1556-1560. doi:10.1097/01.TP.0000058745.02123.6F 41   59 Cited 62 times in Scopus62 0